华东医药猫用GLP-1/GIP双靶产品申报上市;康方生物首款三抗申报临床

氨基观察
Dec 30, 2025

肥胖猫也要有减肥药用了。12月29日,华东医药宣布,其全资子公司中美华东收到农业农村部发出的《受理通知书》,普瑞泊肽注射液一类新兽药上市注册申请获得受理,申报适应症为:成年肥胖猫的体重管理。康方生物正式开启三抗之路。12月29日,CDE官网显示,已受理康方生物递交的其首款三抗新药AK150的临床申请。这是一款调节肿瘤微环境巨噬细胞的三靶点抗体(ILT2/ILT4/CSF1R)。在过去的一天里,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10